Please use this identifier to cite or link to this item: https://doi.org/10.1177/0896860819887626
Title: Retraining for prevention of peritonitis in peritoneal dialysis patients : A randomized controlled trial
Authors: Ljungman, Susanne
Jensen, Jørgen E.
Paulsen, Dag
Petersons, Aivars
Peritonitis Prevention Study (PEPS) Trial Investigators
Keywords: Follow-up;patient compliance;patient education;patient knowledge;prevention;prophylaxis;reeducation;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Nephrology
Issue Date: 1-Mar-2020
Citation: Ljungman , S , Jensen , J E , Paulsen , D , Petersons , A & Peritonitis Prevention Study (PEPS) Trial Investigators 2020 , ' Retraining for prevention of peritonitis in peritoneal dialysis patients : A randomized controlled trial ' , Peritoneal Dialysis International , vol. 40 , no. 2 , pp. 141-152 . https://doi.org/10.1177/0896860819887626
Abstract: Background: Peritonitis is more common in peritoneal dialysis (PD) patients nonadherent to the PD exchange protocol procedures than in compliant patients. We therefore investigated whether regular testing of PD knowledge with focus on infection prophylaxis could increase the time to first peritonitis (primary outcome) and reduce the peritonitis rate in new PD patients. Methods: This physician-initiated, open-label, parallel group trial took place at 57 centers in Sweden, Denmark, Norway, Finland, Estonia, Latvia, the Netherlands, and the United Kingdom from 2010 to 2015. New peritonitis-free PD patients were randomized using computer-generated numbers 1 month after the start of PD either to a control group (n = 331) treated according to center routines or to a retraining group (n = 340), which underwent testing of PD knowledge and skills at 1, 3, 6, 12, 18, 24, 30, and 36 months after PD start, followed by retraining if the goals were not achieved. Results: In all, 74% of the controls and 80% of the retraining patients discontinued the study. The groups did not differ significantly regarding cumulative incidence of first peritonitis adjusted for competing risks (kidney transplantation, transfer to hemodialysis and death; hazard ratio 0.84; 95% confidence interval (CI) 0.65–1.09) nor regarding peritonitis rate per patient year (relative risk 0.93; 95% CI 0.75–1.16). Conclusions: In this randomized controlled trial, we were unable to demonstrate that regular, targeted testing and retraining of new PD patients increased the time to first peritonitis or reduced the rate of peritonitis, as the study comprised patients with a low risk of peritonitis, was underpowered, open to type 1 statistical error, and contamination between groups.
Description: Funding Information: The author(s) received no financial support for the research, authorship, and/or publication of this article: This trial was supported by The Health & Medical Care Committee of The Regional Executive Board, Region West of Sweden, Sweden (VGFOUREG-78061, 226521, and 383641), Baxter Healthcare Corporation (McGaw Park, IL, USA; Clinical Evidence Council grant number 10CECEU1004), Swedish Society of Nephrology, The Swedish Kidney Association, The Society of Kidney Patients in Region West of Sweden, The John and Brit Wennerström Foundation, The Foundation for Kidney Failure (Sweden), The Swedish Kidney Foundation, and the Norwegian Society of Kidney Patients. Publisher Copyright: © The Author(s) 2020. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
DOI: https://doi.org/10.1177/0896860819887626
ISSN: 0896-8608
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.